已收盤 11-20 16:00:00 美东时间
-0.410
-20.50%
今日重点评级关注:韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从42美元升至44美元;HC Wainwright & Co.:维持WhiteFiber"买入"评级,目标价从34美元升至36美元
11-12 19:19
HC Wainwright & Co. analyst Matthew Caufield maintains Upstream Bio (NASDAQ:UPB) with a Buy and lowers the price target from $36 to $18.
11-11 19:36
Upstream Bio (NASDAQ:UPB) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.72) by 4.17 percent. This is a 19.05 percent decrease over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $395.000 thousand...
11-10 20:34
今日重点评级关注:Tigress Financial:维持Liftoff Mobile"买入"评级,目标价从39美元升至41美元;奥本海默:维持SpaceX"跑赢大市"评级,目标价从250美元升至280美元
09-03 13:50
HC Wainwright & Co. analyst Matthew Caufield reiterates Upstream Bio (NASDAQ:UPB) with a Buy and maintains $36 price target.
09-02 19:25
今日重点评级关注:富瑞:维持ProMIS Neurosciences"买入"评级,目标价从69美元升至100美元;Benchmark:维持Cineverse"买入"评级,目标价从12美元升至14美元
08-17 13:37
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从49美元升至56美元;韦德布什:维持Zura Bio"跑赢大市"评级,目标价从15美元升至22美元
08-13 11:44
Truist Securities analyst Danielle Brill maintains Upstream Bio (NASDAQ:UPB) with a Buy and lowers the price target from $43 to $25.
08-13 01:39
Upstream Bio (NASDAQ:UPB) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.76) by 3.95 percent. This is a 1.35 percent increase over losses of $(0.74) per share from the same period last year. The company reported quarterly sales of $773.000 thousand wh...
08-11 19:33
今日重点评级关注:Piper Sandler:维持Tenax Therapeutics"超配"评级,目标价从20美元升至50美元;Tigress Financial:维持优步"买入"评级,目标价从110美元升至115美元
06-15 08:32